✦ LIBER ✦

Bortezomib and High-Dose Melphalan as a Novel Conditioning Regimen for Patients With Poems Syndrome Undergoing Autologous Peripheral Blood Stem Cell Transplantation

✍ Scribed by X. Tang; X. Shi; X. Hu; S. Xue; H. Qiu; Y. Han; L. Yan; H. Zhou; Y. Liu; B. Gu; A. Sun; D. Wu

Book ID: 116282104
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.153

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Busulfan and melphalan as conditioning r

Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

✍ A. Alegre; M. Lamana; R. Arranz; M. J. Fernández-Villalta; J. F. Tomás; A. Figue 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

Mitoxantrone and melphalan as a conditio

Mitoxantrone and melphalan as a conditioning regimen for autologous peripheral blood stem cell transplantation in adults with acute myelogenous leukemia

✍ K.A. Sprague; V.A. Padgaonkar; A.K. Klein; G.W. Chan; K.B. Miller; H. Klingemann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Cardiomyopathy Following High Dose Melph

Cardiomyopathy Following High Dose Melphalan Conditioning Prior to Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma and Primary Amyloidosis

✍ J.S. Bleeker; M.A. Gertz; P.A. Pellikka; F. Buadi; D. Dingli; A. Dispenzieri; S. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

High-dose idarubicine, busulphan and mel

High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study

✍ Meloni, G; Capria, S; Trasarti, S; Ferrazza, G; Micozzi, A; Petrucci, M T; Simon 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Amifostine reduces mucosal damage after

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma

✍ Thieblemont, C; Dumontet, C; Saad, H; Roch, N; Bouafia, F; Arnaud, P; Hequet, O; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

A Phase II study of 153Sm-EDTMP and high

A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Angela Dispenzieri; Gregory A. Wiseman; Martha Q. Lacy; Suzanne R. Hayman; Shaji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views